Arms Wide Open Childhood Cancer Foundation Presents $130,000 to the Memorial Sloan Kettering Cancer Center at its 4th Annual Give Thanks for Life Gala

The Grant Will Be Used to Support a Clinical Trial for 30 Children Suffering from Neuroblastoma

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“There is an urgent need to develop newer therapies for children with high risk cancers,” said Dr. Modak.

Staten Island, New York (PRWEB) February 13, 2013

The Arms Wide Open Childhood Cancer Foundation hosted its 4th annual Give Thanks for Life gala at Nicotra’s Ballroom in the Hilton Garden Inn, Staten Island on Friday, February 1, 2013.

Hosting over 250 guests, the evening celebrated the lives of children who are battling cancer and in memory of those who have lost their fight. In attendance were some of the nations top pediatric cancer oncologists and researchers, including Dr. Peter C. Adamson, Chair of the Children’s Oncology Group and Dr. Michael P. LaQuaglia, Chief of the Pediatric Surgical Service at Memorial Sloan Kettering Cancer Center.

In a heartfelt speech, 11 year-old Annie Bartosz, recipient of the Special Sibling Award of Courage declared that she is determined to make a difference in this world for other children and families who are battling cancer after losing her twin brother, Jack, to neuroblastoma just a few months ago,.

A $130,000 check was presented to Dr. Shakeel Modak of the Neuroblastoma Team of Memorial Sloan Kettering Cancer Center in New York City. This grant, donated by AWOCCF and the I Back Jack Foundation, will be used to support a clinical trial for 30 children suffering from neuroblastoma, which is a rare form of pediatric cancer.

“There is an urgent need to develop newer therapies for children with high risk cancers,” said Dr. Modak. “The focus of the current grant is to study the targeting and distribution of hu3f8 when it is injected into patients. This will provide invaluable information for the design of future safer and more effective trials using hu3f8. If good targeting is observed, radiolabeled hu3f8 can also be used in the therapy of patients with neuroblastoma and other solid tumors of children,” concluded Dr. Modak.

For additional information about Arms Wide Open Childhood Cancer Foundation, please visit http://www.AWOCCF.org

About Arms Wide Open Childhood Cancer Foundation
On July 6, 2008, the lives of Dena and Billy Sherwood changed forever when their then 13-month-old son, Billy Jr., was diagnosed with neuroblastoma, a very aggressive cancer of the sympathetic nervous system that most commonly occurs in infants and children under the age of five. In August of 2009, in the midst of their son's aggressive treatment, Dena and Billy founded Arms Wide Open Childhood Cancer Foundation.
Arms Wide Open Childhood Cancer Foundation is working closely with scientists, researchers and doctors; who are pioneers in the pediatric cancer field, who are on the forefront of bringing many alternative therapies into clinic which could prolong the lives of children diagnosed with Neuroblastoma until a cure is funded. Right now only 30% of children diagnosed with High Risk Neuroblastoma will survive, but because it is an "orphan" cancer, research funding is limited as pharmaceutical companies do not see the efforts as profitable. Recognizing that children should not be viewed as a profit, but, rather, our investment, Arms Wide Open raises money for alternative therapies and actual treatments these children so desperately need in order to survive

###


Contact

  • Dena Sherwood
    Arms Wide Open Childhood Cancer Foundation
    732-904-2799
    Email